X-Ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor.

作者信息

Bohacek R S, Dalgarno D C, Hatada M, Jacobsen V A, Lynch B A, Macek K J, Merry T, Metcalf C A, Narula S S, Sawyer T K, Shakespeare W C, Violette S M, Weigele M

机构信息

ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139-4234, USA.

出版信息

J Med Chem. 2001 Mar 1;44(5):660-3. doi: 10.1021/jm0002681.

DOI:10.1021/jm0002681

PMID:11262076

Abstract

摘要

相似文献

X-Ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor.

J Med Chem. 2001 Mar 1;44(5):660-3. doi: 10.1021/jm0002681.

A novel phosphotyrosine mimetic 4'-carboxymethyloxy-3'-phosphonophenylalanine (Cpp): exploitation in the design of nonpeptide inhibitors of pp60(Src) SH2 domain.

Bioorg Med Chem Lett. 2001 Sep 3;11(17):2319-23. doi: 10.1016/s0960-894x(01)00446-2.

Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity.基于结构设计的具有体内抗吸收活性的破骨细胞选择性非肽Src同源2抑制剂

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9373-8. doi: 10.1073/pnas.97.17.9373.

SAR and X-ray. A new approach combining fragment-based screening and rational drug design: application to the discovery of nanomolar inhibitors of Src SH2.

J Med Chem. 2002 Jun 6;45(12):2379-87. doi: 10.1021/jm010927p.

Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors.低亲和力抑制剂片段与（pp60）Src的SH2结构域特异性结合的要求与全长抑制剂的高亲和力结合要求相同。

J Med Chem. 2003 Nov 20;46(24):5184-95. doi: 10.1021/jm020970s.

Structure-based design of novel nonpeptide inhibitors of the Src SH2 domain:phosphotyrosine mimetics exploiting multifunctional group replacement chemistry.基于结构的Src SH2结构域新型非肽抑制剂的设计：利用多功能基团置换化学的磷酸酪氨酸模拟物

Biopolymers. 2003;71(6):717-29. doi: 10.1002/bip.10600.

Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.pp60（c-src）SH2结构域的肽配体：一项热力学与结构研究。

Biochemistry. 1997 May 27;36(21):6283-93. doi: 10.1021/bi970019n.

Potent dipeptide inhibitors of the pp60c-src SH2 domain.pp60c-src SH2结构域的强效二肽抑制剂。

J Med Chem. 1998 May 21;41(11):1894-908. doi: 10.1021/jm970853a.

Principles governing the binding of a class of non-peptidic inhibitors to the SH2 domain of src studied by X-ray analysis.

J Med Chem. 2002 Jul 4;45(14):2915-22. doi: 10.1021/jm0110800.

Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.Src SH2结构域-酪氨酰磷酸肽界面间能量偶联的剖析。

J Mol Biol. 2002 Feb 15;316(2):291-304. doi: 10.1006/jmbi.2001.5362.

引用本文的文献

Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.利用代谢组学偏向性片段晶体学发现白三烯A4水解酶抑制剂。

J Med Chem. 2009 Aug 13;52(15):4694-715. doi: 10.1021/jm900259h.

Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.信号转导与转录激活因子的构象受限拟肽抑制剂。3：评估与分子建模。

J Med Chem. 2009 Apr 23;52(8):2429-42. doi: 10.1021/jm801491w.

Design and synthesis of phosphotyrosine peptidomimetic prodrugs.磷酸酪氨酸拟肽前药的设计与合成。

J Med Chem. 2006 Jun 1;49(11):3368-76. doi: 10.1021/jm060142p.

Structural basis of hereditary coproporphyria.遗传性粪卟啉原增多症的结构基础。

Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14232-7. doi: 10.1073/pnas.0506557102. Epub 2005 Sep 21.

NMR structure of a complex between MDM2 and a small molecule inhibitor.MDM2与一种小分子抑制剂复合物的核磁共振结构

J Biomol NMR. 2004 Oct;30(2):163-73. doi: 10.1023/B:JNMR.0000048856.84603.9b.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验